Skip to main content

Table 1 Demographics and baseline characteristics of patients

From: A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward

  All patients Patients not admitted to hospital Hospitalized, discharged alive Hospitalized, deceased
n = 58 n = 22 n = 22 n = 14
Demographics
 Age (years) 67 [12.5] 64 [11.5] 71 [18.5] 68 [8]
 Sex (male) 52% (30) 32% (7) 68% (15) 57% (8)
 Race (non-White) 63% (36/57) 55% (12) 55% 12 92% (12)
 BMI (kg/m2) 27.6 [7.9] 26.1 [5.3] 28.2 [10.2] 29.5 [9.9]
 Obesity (BMI > 30 kg/m2) 37% (21/57) 27% (6) 38% (8/21) 50% (7)
Comorbidities
 High cardiovascular risk profile (≥ 2 of hypertension, hyperlipidemia, diabetes) 55% (32) 36% (8) 64% (14) 71% (10)
  Hypertension 64% (37) 59% (13) 59% (13) 79% (11)
  Hyperlipidemia 62% (36) 50% (11) 59% (13) 86% (12)
  Diabetes 28% (16) 9% (2) 45% (10) 29% (4)
 Previous atherosclerotic complications (CAD and/or CVA) 22% (13) 0% (0) 36% (8) 36% (5)
  Congestive heart failure 12% (7) 0% (0) 14% (3) 29% (4)
  Current or former smoker 37% (21/57) 27% (6) 38% (8/21) 50% (7)
 Lung disease (COPD, emphysema, asthma, bronchiectasis) 21% (12) 18% (4) 27% (6) 14% (2)
 Chronic kidney disease (eGFR < 60 mL/min) 24% (14) 23% (5) 27% (6) 21% (3)
  History of other malignancy 9% (5) 5% (1) 5% (1) 21% (3)
  Number of comorbidities 2 [3] 1 [1.75] 3 [3] 3.5 [1.75]
Concomitant medication
 Anticoagulation 21% (12) 9% (2) 27% (6) 29% (4)
 Aspirin 59% (34) 59% (13) 59% (13) 57% (8)
 Statin 47% (27) 14% (3) 59% (13) 79% (11)
 ACE inhibitor or angiotensin II receptor blocker 45% (26) 36% (8) 41% (9) 64% (9)
 Beta blocker 34% (20) 9% (2) 50% (11) 50% (7)
 Metformin 16% (9) 5% (1) 32% (7) 7% (1)
 Non-steroidal anti-inflammatory drug 5% (3) 5% (1) 5% (1) 7% (1)
 Oral corticosteroids 53% (31) 45% (10) 50% (11) 71% (10)
 COVID-19 confirmed by PCR at MSH 71% (41) 59% (13) 86% (19) 64% (9)
  1. Note: values are presented as percentage (n) or median [interquartile range]
  2. Abbreviations: BMI body mass index, CAD coronary artery disease, CVA cerebrovascular accident, COPD chronic obstructive pulmonary disease, eGFR estimated glomerular filtration rate, ACE angiotensin-converting enzyme, NSAID non-steroidal anti-inflammatory drug, MSH Mount Sinai Hospital